Page last updated: 2024-08-17

coenzyme a and Bronze Diabetes

coenzyme a has been researched along with Bronze Diabetes in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Ayciriex, S; Cavestro, C; Di Meo, I; Fu, T; Lavermicocca, L; Levi, S; Ligorio, S; Manocchio, A; Mitro, N; Pedretti, S; Ripamonti, M; Santambrogio, P; Tiranti, V	1
Dölle, W; Martini, GA; Strohmeyer, G	1

Other Studies

2 other study(ies) available for coenzyme a and Bronze Diabetes

Article	Year
Neuronal Ablation of CoA Synthase Causes Motor Deficits, Iron Dyshomeostasis, and Mitochondrial Dysfunctions in a CoPAN Mouse Model. International journal of molecular sciences, 2020, Dec-19, Volume: 21, Issue:24 Topics: Animals; Coenzyme A; Coenzyme A Ligases; Female; Hemochromatosis; Homeostasis; Iron; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Diseases; Motor Disorders; Pantothenate Kinase-Associated Neurodegeneration; Synapsins	2020
[What is certain in the therapy of liver patients?]. Der Internist, 1969, Volume: 10, Issue:12 Topics: Anabolic Agents; Ascites; Coenzyme A; Coenzymes; Cortisone; Diet Therapy; Disaccharides; Exchange Transfusion, Whole Blood; Fatty Liver; Hemochromatosis; Hepatic Encephalopathy; Hepatitis; Hepatolenticular Degeneration; Humans; Hypertension, Portal; Immunosuppressive Agents; Liver Cirrhosis; Liver Diseases; NAD; Punctures; Rest	1969

Article

Year

Neuronal Ablation of CoA Synthase Causes Motor Deficits, Iron Dyshomeostasis, and Mitochondrial Dysfunctions in a CoPAN Mouse Model.

International journal of molecular sciences, 2020, Dec-19, Volume: 21, Issue:24

Topics: Animals; Coenzyme A; Coenzyme A Ligases; Female; Hemochromatosis; Homeostasis; Iron; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Diseases; Motor Disorders; Pantothenate Kinase-Associated Neurodegeneration; Synapsins

2020

[What is certain in the therapy of liver patients?].

Der Internist, 1969, Volume: 10, Issue:12

Topics: Anabolic Agents; Ascites; Coenzyme A; Coenzymes; Cortisone; Diet Therapy; Disaccharides; Exchange Transfusion, Whole Blood; Fatty Liver; Hemochromatosis; Hepatic Encephalopathy; Hepatitis; Hepatolenticular Degeneration; Humans; Hypertension, Portal; Immunosuppressive Agents; Liver Cirrhosis; Liver Diseases; NAD; Punctures; Rest

1969